Resources from the same session
Individual tailoring of risk assessment for germline variants beyond BRCA
Presenter: Kelly-Anne Phillips
Session: Actionability of germline variants beyond BRCA 1 and 2
Resources:
Slides
Webcast
Systemic therapy horizons for hereditary breast cancer beyond BRCA
Presenter: Judith Balmana
Session: Actionability of germline variants beyond BRCA 1 and 2
Resources:
Slides
Webcast
Q&A and discussion
Session: Actionability of germline variants beyond BRCA 1 and 2
Resources:
Webcast